The Evidence for and Against Corticosteroid Prophylaxis in At-Risk Patients.

Matthew S Davenport, Richard H Cohan

Journal: Radiologic clinics of North America 2017;55(2):413-421

PMID: 28126223

Abstract

Corticosteroid prophylaxis is commonly used for the prevention of allergiclike reactions to iodinated and gadolinium-based contrast material in patients at highest risk of an allergiclike reaction. However, it has only a weak mitigating effect on allergiclike reactions, probably does not affect the severity of subsequent reactions, and does not prevent all reactions. Breakthrough reactions occur, are usually the same severity as the index reaction, and can occasionally be life threatening. Premedication of inpatients is likely associated with substantial cost and harm because of hospital length-of-stay prolongation; these indirect effects may exceed the benefits of premedication in this population.

Copyright © 2016 Elsevier Inc. All rights reserved.

Address: Department of Radiology and Urology, Michigan Radiology Quality Collaborative, University of Michigan Health System, 1500 East Medical Center Drive, B2-A209P, Ann Arbor, MI 48109, USA. Electronic address: [email protected].; Department of Radiology, University of Michigan Health System, 1500 East Medical Center Drive, B2-A209P, Ann Arbor, MI 48109, USA.
Bant logo

© Copyright 2026, Nutrition Evidence

NED wishes to thank the following organisations for their support:

We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.